Oklo COO Caroline Cochran reports 80,000 shares sold
The sales were made under a Rule 10b5-1 plan adopted March 31, 2025, and included shares held by Caroline Cochran’s spouse, Jacob DeWitte.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Oklo Inc. Co-Founder, COO and director Caroline Cochran reported 80,000 shares of Class A Common Stock sold on November 2, 2026, through direct sales and sales of shares held by her spouse, Jacob DeWitte. The three reported share and weighted-average price tranches were 16,750 at $23.8194, 16,550 at $25.0451 and 6,700 at $25.6903 per share for each ownership category. The sales were made pursuant to a Rule 10b5-1 plan adopted March 31, 2025.
Indirect holdings listed on November 2, 2026 were Caroline DeWitte Family Trust, 7,583,085 shares; Caroline Cochran GRAT, 509,479; Caroline DeWitte GRAT No. 2, 1,000,000; Caroline DeWitte GRAT No. 3, 474,011; Jacob DeWitte Family Trust, 7,851,901; Jacob DeWitte GRAT, 476,483; Jacob DeWitte GRAT No. 2, 1,000,000; and Jacob DeWitte GRAT No. 3, 506,807 shares.
Insider Trade Summary 10b5-1
Net Seller: 80,000 shares
Net Sell
6 txns
Insider
Cochran Caroline
Role
Co-Founder, COO
Sold
80,000 shs ($1.97M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Class A Common Stock F1, F2, F3 | 16,750 | $23.8194 | $399K |
| Sale | Class A Common Stock F1, F4, F3 | 16,550 | $25.0451 | $414K |
| Sale | Class A Common Stock F1, F5, F3 | 6,700 | $25.6903 | $172K |
| Sale | Class A Common Stock F1, F2, F6 | 16,750 | $23.8194 | $399K |
| Sale | Class A Common Stock F1, F4, F6 | 16,550 | $25.0451 | $414K |
| Sale | Class A Common Stock F1, F5, F6 | 6,700 | $25.6903 | $172K |
| Holding | Class A Common Stock F3 | -- | -- | -- |
| Holding | Class A Common Stock F3 | -- | -- | -- |
| Holding | Class A Common Stock F3 | -- | -- | -- |
| Holding | Class A Common Stock F3 | -- | -- | -- |
| Holding | Class A Common Stock F6 | -- | -- | -- |
| Holding | Class A Common Stock F6 | -- | -- | -- |
| Holding | Class A Common Stock F6 | -- | -- | -- |
| Holding | Class A Common Stock F6 | -- | -- | -- |
Holdings After Transaction:
Class A Common Stock — 318,039 shares (Direct);
Class A Common Stock — 351,533 shares (Indirect, By Jacob DeWitte);
Class A Common Stock — 7,583,085 shares (Indirect, By the Caroline DeWitte Family Trust);
Class A Common Stock — 509,479 shares (Indirect, By Caroline Cochran GRAT);
Class A Common Stock — 1,000,000 shares (Indirect, By Caroline DeWitte GRAT No. 2);
Class A Common Stock — 474,011 shares (Indirect, By Caroline DeWitte GRAT No. 3);
Class A Common Stock — 7,851,901 shares (Indirect, By the Jacob DeWitte Family Trust);
Class A Common Stock — 476,483 shares (Indirect, By Jacob DeWitte GRAT);
Class A Common Stock — 1,000,000 shares (Indirect, By Jacob DeWitte GRAT No. 2);
Class A Common Stock — 506,807 shares (Indirect, By Jacob DeWitte GRAT No.3)
Footnotes (6)
- F1. The sales reported herein were effected pursuant to a Rule 10b5-1 plan adopted on March 31, 2025.
- F2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.46-$24.45 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- F3. For more information about the equity of the Issuer held by the Reporting Person, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission.
- F4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.46-$25.45 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- F5. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.47-$25.89 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- F6. For more information about the equity of the Issuer held by the Reporting Person's spouse, please see the Issuer's most recent definitive proxy statement filed with the Securities and Exchange Commission. Represents securities held by the Reporting Person's spouse.
Key Figures
Total shares sold: 80,000 shares
First sale tranche: 16,750 shares per reported sale at a weighted-average $23.8194 per share
Second sale tranche: 16,550 shares per reported sale at a weighted-average $25.0451 per share
+2 more
5 metrics
Total shares sold
80,000 shares
Sales reported for November 2, 2026
First sale tranche
16,750 shares per reported sale at a weighted-average $23.8194 per share
Direct sale by Caroline Cochran and separate spouse-held sale by Jacob DeWitte; November 2, 2026
Second sale tranche
16,550 shares per reported sale at a weighted-average $25.0451 per share
Direct sale by Caroline Cochran and separate spouse-held sale by Jacob DeWitte; November 2, 2026
Third sale tranche
6,700 shares per reported sale at a weighted-average $25.6903 per share
Direct sale by Caroline Cochran and separate spouse-held sale by Jacob DeWitte; November 2, 2026
Rule 10b5-1 plan adoption date
March 31, 2025
The reported sales were made pursuant to this plan
Key Terms
Rule 10b5-1 plan, weighted average price, GRAT
3 terms
Rule 10b5-1 plan regulatory
"sales were effected pursuant to a Rule 10b5-1 plan"
A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.
weighted average price financial
"Column 4 is a weighted average price"
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
GRAT financial
"Caroline Cochran GRAT"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.
